ELTX
Elicio Therapeutics Inc.
1.90$
-2.1%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +13.4% | -44.5% | – | – | +170.4% | +1,676.8% | -93.6% | -100.0% | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | -2.8% | -44.4% | – | – | +5.3% | +202.3% | -65.2% | – | – | +1.4% | -83.7% | – | – | – | +1.4% | +1.0% | -1.0% | +5.2% | -8.9% | +1.1% | +0.7% | +1.1% | +1.0% | – | – | |
| – | – | – | +49.6% | -44.7% | – | – | +272.2% | +1,934.2% | -94.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -77.2% | +412.6% | -50.1% | +82.0% | -58.8% | +216.7% | -8.1% | -49.9% | +75.3% | -56.7% | -8.9% | -13.0% | +37.2% | -9.8% | +46.9% | -15.2% | +22.8% | +8.2% | -11.9% | +47.4% | -26.8% | -9.9% | -28.1% | +0.8% | +32.1% | +1.5% | – | |
| – | – | – | – | – | – | – | – | – | +45.0% | -25.2% | -1.2% | +42.0% | +38.9% | +22.1% | +23.8% | -7.8% | -17.1% | +2.3% | +14.3% | -11.8% | +6.9% | +4.3% | -2.6% | +25.1% | +2.2% | -5.9% | – | |
| – | -79.2% | +481.2% | -31.8% | +17.7% | -55.9% | +200.0% | -8.5% | -37.4% | +49.3% | -60.8% | -7.4% | -1.8% | +37.7% | -0.4% | +38.5% | -15.5% | +9.3% | +6.8% | -5.4% | +31.0% | -20.6% | -3.5% | -20.3% | +9.9% | +16.6% | +1.1% | – | |
| – | – | – | – | – | – | – | – | – | -199.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +429.8% | +117.0% | – | – | – | – | – | – | +1.0% | -91.6% | +276.5% | +108.8% | -99.9% | +100.0% | +1,700.0% | +36.1% | +179.6% | +70.8% | -24.8% | +10.2% | +119.6% | -20.9% | +20.8% | +0.7% | – | |
| – | – | – | – | – | – | – | – | – | -195.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -57.0% | -26.2% | -246.5% | – | – | +1,700.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -195.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -192.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.